We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
441 result(s) found, displaying 311 to 320
-
Cancellation by sponsorRequested by Fresenius Kabi Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 40 mg/20 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 100 mg/10 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 75 mg/10 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 200 mg/100 mL solution for infusion bag.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 20 mg/10 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 150 mg/20 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 400 mg/200 mL solution for infusion bag.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 200 mg/20 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 50 mg/10 mL solution for injection ampoule.